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Objective: The aim of our study was to evaluate clinical and pathological data in order to
draw eligibility criteria for oncologically sufficient radical trachelectomy (RT) in early-stage
cervical cancer. Reviewing all cases of attempted RT performed at our unit, we focused
attention on prognostic indicators of the need for additional oncologic treatment following
RT. The analysis was extended by extensive literature review to include previously published
cases of oncologic failures.
Methods: The authors retrospectively analyzed data of patients who underwent RT at the
Department of Obstetrics and Gynecology, University of Debrecen. Electronic records and
case notes of RT cases were reviewed to determine the incidence of abdominal and vaginal
route, distribution of clinicopathologic data, and follow-up results of individual cases.
Individual procedures were categorized as oncologically insufficient if additional oncologic
treatment was necessary following RT. Theoretical eligibility criteria for RT in early-stage
cervical cancer were determined retrospectively by selecting prognostic features that
were associated with oncologic insufficiency from clinicopathologic indicators of the
complete series.
Results: Twenty-four cases of RT were performed by the authors, 15 vaginal RTs with
laparoscopic pelvic lymphadenectomy and 9 abdominal RTs with open pelvic lymphade-
nectomy. Fifteen of 24 cases proved oncologically sufficient. Three cases required imme-
diate conversion to radical hysterectomy because of positive sentinel nodes and/or positive
isthmic disc on frozen section. In further 5 cases, final pathology results indicated additional
oncologic treatment, that is, radical hysterectomy (n = 2), chemoradiotherapy (n = 2), or
chemotherapy (n = 1). One patient among immediately converted cases and another 3 among
those who required additional oncologic treatment died of their disease later. There were no
other cases of recurrences over a median follow-up of 34 months (range, 12Y188 months).
Factors that may predict oncologic insufficiency of RTwere stage IB1 or greater, tumor size
of greater than 2 cm in 1 dimension or greater than 15mm in 3 dimensions, G3, nonsquamous/
adeno histological type, stromal invasion of greater than 9 mm, and lymphovascular space
involvement in the primary tumor.
Conclusions: Most cases of oncologically insufficient RTs have significant risk features
that can be identified preoperatively. There is a need for more clinicopathologic data on
oncologic failure of RT cases in order to improve patient selection.
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Cervical cancer is the third most common malignant dis-ease among women. In the last few decades, the average
age of women at first confinement has been increasing, while
the mean age at diagnosis of cervical cancer patients has
been decreasing. These facts lead to an increasing number of
women requesting fertility-preserving treatment for cervical
cancer. Radical hysterectomy is an effective treatment method
of early-stage cervical cancer (stages IA1YIIA) with 73.4%
to 97.5% 5-year overall survival, but this technique is not
without complications. This operation carries a significant
morbidity that is related to bleeding, vessel and nerve injury,
and bladder and bowel dysfunction. Postoperatively, there is
considerable risk of fistula formation, lymphedema, sexual
dysfunction, and the ultimate loss of fertility. Therefore, it is
not surprising that a growing intention for less invasive in-
terventions in early-stage cervical cancer has arisen over the
last few decades. Conization and simple hysterectomy seem
an acceptable alternative treatment inmicroinvasive carcinoma.
Although radical hysterectomy remained the recommended
treatment method in early-stage (IA2Y1B1) disease, in cases
where fertility preservation is desired, radical trachelectomy
(RT) can be an appropriate alternative method.1,2 The aim
during radical vaginal RT (VRT) is to excise the cervix together
with the associated parametrium and upper vaginal cuff in
addition to a pelvic lymphadenectomy (PLND) performed via
laparoscopy (LSC PLND). Soon after the introduction of the
Dargent technique of VRT in the early 1990s, Hungarian gy-
necologic oncologists contributed to the elaboration of the
technique of abdominal RT (ART).3,4 Generally, the abdominal
route gives an opportunity for a wider parametrial dissection.
Although RT can preserve fertility, the operation carries a
considerable risk of perioperative morbidity that is mostly re-
lated to parametrectomy. In contrast, VRT requires a more
experienced surgeon and is technically more challenging, but
recovery time is shorter, the incidence of perioperative mor-
bidity is lower, and LSC PLND is equivalent to open PLND.
Nowadays, RT is performed in more and more departments via
laparoscopy. The advantage ofARToverVRT is that it provides
an opportunity for awider parametrial dissection and in special
cases allows excision of tumors with a larger diameter.5
Within the literature of RT, most articles are retro-
spective, present a small number of cases, and contain levels II
and III recommendations. More importantly, most reports
do not give specific details regarding the oncologically in-
sufficient cases, that is, those cases of RTs that were either
aborted or required additional oncologic treatment such as
radical hysterectomy, chemoradiation, or chemotherapy. Intention-
to-treat (ITT) analysis was introduced in medical research
methodology in the 1990s. As compared with per-protocol
analysis, ITT admits noncompliance, protocol deviations, and
dropouts and provides greater accountability for all patients
enrolled into the study. Intention-to-treat analysis gives more
realistic idea about generalizability of the results. The majority
of reports on RTs analyze data of trachelectomies that were
actually performed, and less attention is paid to cases where
failures and protocol deviation occurred or follow-up data are
missing. Ultimately, an aborted trachelectomy or additional
oncologic interventions can be considered as a failed attempt
to treat cervical cancer with RT alone. Probably due to the
relatively short follow-up intervals, most reports do not have
much data about recurrences and do not present details of pa-
tientswho died of their disease. In this study, we summarize our
experiences and present details of not only successful cases,
but also the failed ones. Avoiding publication bias by an ITT
analysis is of crucial importance in helping accurate pa-
tient selection in the future, and it is likely to help avoiding
oncologically insufficient interventions in the future.
METHODS
A retrospective study was conducted on patients in
whom an RT was attempted between 2002 and 2015 at the
Unit of Gynecologic Oncology, Department of Obstetrics and
Gynecology, University of Debrecen. The aim of our study
was to evaluate clinical and pathological data in order to draw
eligibility criteria for oncologically sufficient RT in early-
stage cervical cancer. In our view, the need for additional
oncologic treatment means that RT alone was oncologically
insufficient; therefore, oncologic insufficiency was defined
as a case requiring additional oncotherapy beyond RT. Early
and late outcome data, as well as primary histology, intra-
operative frozen-section histology, and final pathology data,
were subjected to prognostic evaluation in relation to onco-
logic sufficiency of RTs. The results were also compared with
internationally published data and recommendations.
Preoperative magnetic resonance imaging (MRI) or
computed tomography (CT) and chest radiography were per-
formed in all cases of RT. Magnetic resonance imaging was the
default abdominopelvic imaging technique in the preoperative
workup; however, in 2 referred cases in which CT scans had
already been performed, pelvic ultrasound findings considered
a subsequent MRI scanning unnecessary.
Patients were eligible for inclusion into the study if RT
was attempted. Patients were considered prospectively eligible
for RT if the extent of the histologically confirmed cervical
cancer was confined to the cervix on preoperative physical
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examination, no extracervical spread was detected on imaging
studies, and therewas a desire to retain fertility.According to the
ITT principle, we did not exclude any cases with attempted RT.
Initially, in patients with early-stage cervical cancer due
for fertility-preserving surgery,we used the technique described
by Dargent et al.1 In ART, we used the technique described by
Palfalvi et al.3,4A cerclage is routinely used to partially close the
internal cervical orifice of the uterus. An intrauterine catheter
wasoccasionally inserted and left in situ for a couple ofweeks to
keep the uterine orifice open and to prevent stricture. Sentinel
nodes were identified with blue-dye technique and were sub-
mitted to frozen-section histology together with a 3- to 5-mm-
thick isthmic disc. Positive result in the dissected isthmic disc or
in the sentinel lymph node was an indication for conversion to
radical hysterectomy. In cases, where intraoperative histology
was negative, but the final histological result was positive, a
consideration of a second operation or adjuvant therapy was
made by the institutional multidisciplinary tumor board.
The route for RTwas primarily determined on the basis
of preoperative prognostic indicators together with the sur-
geon’s and the patients’ preferences. Because local practice,
as well as international practice, has gone through a dynamic
evolution over the years, our protocol for choosing between
vaginal and abdominal approach among the presented cases
has changed significantly over the past years. Because of a
traditionally strong experience in vaginal surgery at our insti-
tute, the first 7 cases of our RTs were performed via the vaginal
route. Then, according to encouraging published results of
ARTs,we startedgaining experiencewith this approach in cases
where vaginal exposure of the paracervical region was deemed
unsatisfactory by the surgeon. With a considerable experience
in both techniques, roughly in the second half of the presented
cases, more stringent criteria were used to choose between the
vaginal and abdominal route. Generally, in stages IB1 and IB2
cases ART was performed, whereas in stages IA1 and IA2
cases VRTwas performed. Among the stage IB2 cases, there
was 1 exception from this approach. In that case, complete
radiological response was achieved following platinum-based
neoadjuvant chemotherapy (NACT), and colposcopic and
physical examination revealed full disappearance of the le-
sion; therefore, VRTwas performed. Among stages IA1 and
IA2 cases, there was 1 exception from the vaginal route be-
cause of positive sentinel node on frozen section. Laparo-
scopic PLND was performed transperitoneally in all VRT
cases. Blue-dye technique was used to identify sentinel nodes
bilaterally, and sentinel nodes were sent for intraoperative
frozen-section histology together with the isthmic disc.
Patients were followed up 3-monthly for 2 years then at
every 6 months. Follow-up assessment included physical
examinations, cytology, and abdominal and pelvic ultrasound
examination. Magnetic resonance imaging studies were
performed on a yearly basis or any time out of schedule when
disease progression was suspected by symptoms or findings
of routine follow-up assessment.
RESULTS
Between 2002 and 2015, 24 patients were scheduled for
ART or VRT in our institution. Vaginal RT was done in 15
patients, and ART in 9 patients. Preoperative MRI was per-
formed before the referral, with the exception of 2 cases
in whom contrast-enhanced 64-slice CTwas performed. The
TABLE 1. Patients’ characteristics
Characteristics
Patients 24
Follow-up, median (range), mo 34 (12Y188)
Age, median (range), y 32 (26Y49)
Parity, n (%)
0 15 (62.5)
1 5 (21)
2 4 (16.5)
Stage, n (%)
IA1 6 (25)
IA2 4 (17)
IB1 9 (37.5)
IB2 3 (12.5)
IIA1 2 (8)
Histology, n (%)
Squamous* 16 (67)
Adenocarcinoma† 8 (33)
Grade, n (%)
1 14 (58)
2 3 (13)
3 7 (29)
LVSI, n (%)
Positive 5 (21)
Negative 19 (79)
Stromal invasion, n (%)
G5 mm 15 (62.5)
5Y10 mm 5 (20.5)
910 mm 4 (17)
Tumor size, n (%)
G1 cm 11 (46)
1Y2 cm 8 (33)
2Y4 cm 4 (17)
94 cm 1 (4)
Residual cancer on final pathology, n (%)
Yes 20 (83)
No 4 (17)
Lymph nodes removed, median (range) 15 (10Y27)
No. of positive nodes, n (%)
0 20 (83)
1 3 (11)
2 1 (4)
*One case with neuroendocrine elements.
†One case with clear cell elements.
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findings of CT scans together with expert transvaginal ul-
trasound assessment were considered as sufficient to waive
MRI scanning. Chest radiography was performed in all cases.
Imaging studies showed no sign of extracervical spread of
the tumor. Characteristics of all cases undergoing RT are
shown in Table 1. No intraoperative complication occurred
and no greater than grade I postoperative complication oc-
curred according to the Clavien-Dindo classification.
Among 9 ART cases, preoperative histology confirmed
4 squamous, 3 adenocarcinoma, 1 neuroendocrine, and 1
clear cell tumors. The latter 2 cases were initially diagnosed as
squamous type and adenocarcinoma, respectively. The mean
of the largest diameter of the primary tumor and the mean
depth of stromal invasionwere 17.5mmand7mm, respectively.
Three (33%) of the 9 ART cases had lesion of more than 2 cm.
Lymphovascular space involvement (LVSI) was found in 4
cases. Intraoperative frozen-section histology was positive in
2 cases; therefore, RT was considered as oncologically insuf-
ficient, and the operationwas converted to radical hysterectomy
(Table 2, patients 5 and 7).With regard to obstetric outcome, no
pregnancy has occurred so far among our ART cases.
Among 15 VRT cases, there were 11 squamous and 4
adenocarcinoma histological types. The mean of the largest
diameter of the primary tumor and the mean depth of stromal
invasion were 12.5 mm and 3 mm, respectively. Three (20%)
of the 15 VRT cases had lesion of more than 2 cm. Lympho-
vascular space involvement was found in 1 case. Intraoperative
frozen section was positive in 2 cases. In the first case, lymph
nodemappingwas performed, and only 1 proximal lymph node
contained a 1-mm-diameter subcapsular metastasis (Table 3,
patient 3). In view of the small-volume disease and no LVSI on
primary histology, a decision was made not to convert the
procedure into radical abdominal hysterectomy. Final pathol-
ogy confirmed microscopic residual disease in the cervix with
wide clear margins of more than 1 cm and no further lymph
node involvement. The patient is well with no evidence of
disease at 36 months after the procedure. The other case with
positive intraoperative histology had positive margin of the
isthmic disc; therefore, the procedure was converted to radical
abdominal hysterectomy (Table 2, patient 4). At 87 months of
follow-up, she has no evidence of disease. Themean follow-up
time of VRT patients was 58 months (range, 21Y188 months).
One patient among our VRT cases had radical abdominal
hysterectomy based on the final pathology findings (Table 2,
patient 1). Having received postoperative chemoradiotherapy,
shewas diagnosed as having pulmonarymetastasis at 58months.
Platinum-taxane combination chemotherapy resulted in tem-
porary remission, and she died of her disease 121 months after
VRT (Table 4, patient 4). With regard to obstetric outcome,
4 VRT patients have achieved pregnancy so far. One of these
pregnancies ended in a second-trimester abortion, and the other
3 resulted in live birth by elective cesarean delivery at term.
Radical trachelectomy in our series was oncologically
sufficient in 16 of 24 cases (Table 3). In this group of patients,
the final pathology showed 9  8  6-mm average tumor
diameter in 3 dimensions; the largest dissected specimen was
40  35  30 mm. Histologically 11 of 15 were squamous
cell, and 4 of 15 were adenocarcinoma. None of these cases
showed LVSI, and intraoperative frozen-section pathology
showed lymph node metastasis in only 1 of them. The single
subcapsular lymph node metastasis measured 1 mm; no other
mapped lymph nodes showed involvement; therefore, the RT
procedure was not aborted. The moderately differentiated
squamous primary tumor of this case measured 10 10 12
mm and showed 9-mm depth of stromal invasion with wide
clear margins and no LVSI. The final pathology did not reveal
further lymphatic involvement, and the patient’s follow-up
showed no evidence of disease at 36 months after surgery.
Eight cases of RT required additional oncotherapy; hence,
these cases were considered as oncologically insufficient ones
(Table 2). Four of them had abdominal, and another 4 had VRT.
The mean tumor diameter in 3 dimensions was 23  19  16
mm; the largest one was 60 50 30mm. There were 6 cases
with squamous, 1 squamous with neuroendocrine elements,
and 1 adenocarcinoma with clear cell elements. The average
stromal invasion was 5.75 mm; the deepest one was 15 mm. In
TABLE 2. Oncologically insufficient trachelectomies
Patient
Tumor
Size, mm Type Grade
Stromal Invasion,
mm or thirds LVSI
Nodal Status
(Positives/Total) Stage
1 40 40 40 Squamous 3 3/3 1 1/16* IIA
2 10 10 10 Squamous 3 7 0 0/16 IIA
3 7  3  2 Squamous 1 3 0 0/17 IB1
4 3  2  2 Squamous 1 2 0 0/12 1A1
5 20 15 10 Adeno 3 3/3 1 + V1 1/21 1B1
6 30 20 20 Squamous with neuroendocrine
elements
3 10 1 + V1 0/12 1B2
7 60 50 30 Squamous 2 15 1 2/21 1B2
8 14 12 10 Adeno with clear cell elements 3 10 0 0/19 1B1
*Positive node and positive margin revealed by final pathology.
Radical trachelectomy was oncologically insufficient in cases with stage IB1G, grade 3 tumor, deep stromal invasion, positive lymph node,
or LVSI in the primary tumor.
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4 cases, LVSI could be identified in the primary tumor, and in 2
of these cases, positive lymph nodes were also present. Radical
trachelectomy was followed by radical hysterectomy in all
oncologically insufficient cases. Despite additional oncotherapy,
4 of these 8 patients had died of their disease (Table 4).
The 33% rate of additional oncologic treatment in our
series appears to be largely related to risk factors that had been
identified before RT. These factors include bulky lesion, G3
tumor, deep stromal invasion, LVSI, and the presence of
aggressive histological component. Therewere only 2 cases in
which no preoperative high-risk feature could be identified
(Table 2, patients 3 and 4). The first of these 2 cases had
microscopic residual disease on the trachelectomy specimen
and opted for hysterectomy after RT, which revealed moderate
cervical dysplasia in the stump. In patient 4, positive isthmic
disc indicated conversion to radical hysterectomy during the
course of RT. There were 2 cases (Table 2, patients 5 and 7) in
which the intraoperative finding of positive nodes led us to
convert to radical hysterectomy.
DISCUSSION
The management of fertility-sparing surgery must in-
clude a thorough selection of patients and complete infor-
mation about this technique. Besides the possibility of early
and late complications and obstetric outcomes, patients have
to be informed about the potential need for additional surgery,
as well as adjuvant oncologic treatment.6
Current National Comprehensive Cancer Network guide-
lines suggest fertility-preserving surgery in only stage IB tu-
morswith less than2-cmdiameter, and it is not recommended in
cases with gastric-type adenocarcinoma, adenoma malignum,
and neuroendocrinemalignancy.7 Radical trachelectomy is also
recommended as an alternative intervention (level IIB evi-
dence) in stages IA1 and IA2 lesions with positive excision
margin or less than 3-mm intact border with LVSI. One of our
cases with neuroendocrine tumor and another one with clear
cell tumor can be seen as inappropriate inclusions. Indeed,
according to current guidelines, they should not have been
offered fertility preservation on the basis of the final histology.
At the time of the procedure, in 2004, an initial histology
showed squamous histology with scattered foci of neuroen-
docrine elements. A documented response to NACT and the
patient’s request led to the decision to proceed with fertility-
preserving surgery. National Comprehensive Cancer Network
guidelines were updated, with neuroendocrine tumors and
rare-type adenocarcinomas being considered as inappropriate
for RT only at a later date.
According to Pareja and colleagues’8 analysis, the risk
of relapse is increasing with the diameter of tumor. Radical
trachelectomy in a patient with a lesion of more than 2 cm in
largest diameter is therefore not recommended. In their opinion,
goodprognostic factors include less than2-cmdiameter, limited
depth of invasion, absent LVSI, and no positive lymph nodes.
In the presence of these conditions, the risk of parametrial
spread is less than 1%. Plante et al9 formulated bad prognostic
factors in their study to include high-grade tumor, the presence
of LVSI, and greater than 2-cm tumor diameter. Sixty-nine
percent of their cases had IB1 disease; therefore, lesions of
greater than 4 cmmay not be represented in this conclusion. In
Dargent’s original series, the most important risk factor of
relapse was tumor diameter. For this reason, he did not rec-
ommend performing RT tumors with a diameter of greater
than 2 cm.1 Despite these recommendations, a lot of studies
have tried to expand the eligibility criteria of RT. This is
possible especially in ART because wider resection zone can
TABLE 3. Oncologically sufficient trachelectomies
Patient Tumor Size, mm Type Grade Stromal Invasion, mm LVSI Nodal Status (Positive/Total) Stage
1 15  15  10 Adeno 1 3 0 0/12 1A2
2 2  1  1 Squamous 1 1 0 0/14 1A1
3 10  10  12 Squamous 2 9 0 1/10 1B1
4 2  2  2 Adeno 1 2 0 0/14 1A1
5 10  5  3 Adeno 1 3 0 0/11 1B1
6 40  35  30 Squamous 1 7 0 0/14 1B2
7 2  2  1 Squamous 1 1 0 0/13 1A1
8 3  2  2 Squamous 1 2 0 0/16 1A1
9 5  5  4 Squamous 1 4 0 0/12 1A2
10 4  5  3 Squamous 1 3 0 0/12 1B1
11 7  6  3 Adeno 1 3 0 0/12 1B1
12 6  4  2 Squamous 1 2 0 0/15 1A1
13 10  10  10 Adeno 3 7 0 0/18 1B1
14 11  7  3 Squamous 2 3 0 0/27 1A2
15 4  2  2 Squamous 1 1 0 0/13 1A1
16 5  5  3 Squamous 1 3 0 0/19 1A2
In 1 case with stage IB2 and in another case with lymph node micrometastasis, no additional treatment was considered as necessary.
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be achieved compared with VRT.5 Cibula et al10 proposed that
the patient selection for fertility-sparing procedure should be
based on the cranial extent of the tumor rather than on hori-
zontal size or tumor volume. In their opinion, it is a freemargin
of at least 1-cm length along the endocervical canal toward
the internal os that should define eligibility for fertility-
preserving surgery. Indeed, expanding the inclusion criteria
to lesions larger than 2 cm, fertility-sparing surgery may be-
come available for women with locally advanced disease.
Nonetheless, among these patients, the rate of oncologically
insufficient cases is higher; therefore, the need for conversion
and for additional adjuvant chemo/chemoirradiation therapy is
more likely to arise.11
In our view, the need for additional oncologic treatment
means that RT alone is oncologically insufficient. According
to our data in relation to tumor size, trachelectomy was
oncologically not sufficient in stages greater than IB1, in
cases with more than 2-cm primary tumor, and in cases where
the lesion measured more than 15 mm in all 3 dimensions. It
is important to note that these criteria could be overwritten
by NACT, when optimal down-staging had been achieved.
Furthermore, trachelectomy was oncologically insufficient in
cases with a stromal invasion depth of more than 9 mm and in
grade 3 cancers. We also conclude that the procedure should
not be recommended in rare histological types such as neu-
roendocrine or clear cell tumors because of their aggressive
nature, even if these elements are not the predominant features
of the initial histology. The presence of LVSI or vascular space
involvement was also and indicator of the need for additional
oncologic treatment. Positive lymph nodes were used as in-
dication for conversion to radical hysterectomy except in 1
case, in which the exemption was based on favorable asso-
ciated prognostic features.
Plante et al9 are one of the most experienced teams in
performing VRT. Of 140 planned VRTs 125 were actually
performed. Twenty-one percent of their cases had stage IA2
disease, and 69% had stage IB1. Histological grade was G1 in
41% of cases. Histological type was squamous in 56% and
adenocarcinoma in 37% of their cases. In 29%, LVSI was
present, and the largest tumor diameter was less than 2 cm in
88.5% of cases. The median follow-up time was 93 months
(range, 2Y225 months). Relapse rate was 4.8%, and 1.6% of
cases died of their disease.9 In our series, 4 of 15 VRTs proved
to be oncologically insufficient, and only one of them de-
veloped a late distant recurrence, which eventually led to the
patient’s death. The 7% relapse rate in our series is compa-
rable to that in the literature, but the 27% rate of cases re-
quiring additional oncologic treatment is concerning. One
explanation could be the higher rate of lesions of more than
2 cm in our series (33% vs 14%); however, our case numbers
might be considered as too small for such a comparison.
Nevertheless, our cases seem to corroborate Plante and col-
leagues’9 findings that among cases with lesion of more than
2 cm there is a 3 times’ higher risk of abandoning VRT than
among cases with lesion of less than 2 cm (33% vs 11%). In a
recent review of 117 cases with VRT, Zusterzeel et al12 found
high-grade and nonsquamous histology to be associated with
a significantly higher risk of recurrence. Data of our cases
support these findings; however, the histological type ofTA
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adenocarcinoma alone did not seem to confer any negative
prognostic relevance in our series.
Cibula et al10 published 24 cases of ART in 2009.
Preservation of fertility could not be achieved in 7 patients
(29%) as RTwas oncologically insufficient to control disease.
In 4 cases, the excision margins were inadequate, or the
sentinel node was positive; therefore, immediate conversion
to radical hysterectomy followed. In 1 more case, definitive
histology showed inadequate margins, and radical hysterecto-
my was performed as a separate procedure. Additional adju-
vant chemotherapy was instituted in cases with lymph node
micrometastasis or relapse. Themedian follow-upwas 20months.
They reported only 1 case with relapse in which LVSI was not
present, and the lymph nodes were negative (0/28).10 Among
our own cases, 8 patients (33%) required additional oncologic
treatment after RT. Three of themhad intraoperative conversion
to radical hysterectomy, and another 5 patients required addi-
tional operation in the second-line therapy or chemoradiotherapy
according to the results of final pathology. The total number of
ARTs in our series might be considered too small for com-
parison, but it is of note that one third of themhad lesion ofmore
than 2 cm. In Li and colleagues’13 series of 62 ART cases, 12
patients required additional oncologic treatment (immediate
conversion, n = 2; chemotherapy, n = 7; chemoradiation, n = 3),
which can be translated by our terms as oncologically insuffi-
cient cases (19%). In comparison to these results, our rate of 4 of
9 oncologic insufficiency among ART cases might be con-
sidered as too high. Again, the difference might be explained in
part by the higher rate of tumors of more than 2 cm in our series
(33% vs 22%). It is of note that half of the patients in Li and
colleagues’13 report had less than 23 months’ follow-up.
Pareja et al8 reviewed 485 cases based on published
reports. Seventy-one percent of all patients had stage IB1
disease. Relapse rate was similar in the ART group (3.8%) to
that in the VRT group (4.2%). Death rates were 0.4% in the
ART group and 2.9% in the VRT group. The differences were
statistically not significant between the groups in either re-
lapse rate (P = 0.47) or in 5-year progression-free survival
(P = 0.69) or in overall survival. Despite their statistical re-
sults, they concluded that ART is oncologically safer than
VRT. It is of note that 113 (38%) of the 485 patients have
attempted conceiving after the procedure, and 67 of them
(58%) were successful. Of these 67 patients, 47 gave birth to a
healthy newborn, and 18 had a miscarriage. Pregnancy rate
after trachelectomy was similar in both groups.8 In contrast,
Wan et al. published pregnancy rates after ART ranging be-
tween 6.7% and 33.3%, which was lower than those after VRT
(16.7%Y100%).6
Neoadjuvant chemotherapy can overwrite the earlier
established selection criteria, but the applicability of this pre-
sumption demands further investigations.5,14 Robova et al15
investigated the role of NACT. In their publication, 28 cases
with deep stromal invasion and lesions of more than 2-cm di-
ameter were examined. They used cisplatin-ifosfamide com-
bination for the treatment of planocellular carcinomas, while
adenocarcinomas were treated with cisplatin-adriamycin pro-
tocols. On completion of chemotherapy, laparoscopic sentinel
lymph node biopsy was performed. In case of negative frozen-
section result (7%,2 cases), LSCPLNDwascompleted.Having
received the negative results of final pathology, simple trach-
electomy was performed as a second-line surgery. In case of
positive sentinel node or intact margin of less than 8mm of the
trachelectomy specimen (22%, 6 cases), they performed type
C2 radical hysterectomy. In the remaining 20 cases, the relapse
rate was 20%. Two of them have died (10%). The median
follow-up period was 42 months (range, 5Y103 months). In
1 case of our own series, VRT with laparoscopic lymphade-
nectomy was performed after 3 cycles of NACT by BIP
(bleomycin-ifosphamide-cisplatin) protocol in ayoung patient
with stage IB2 disease. Histopathologic review of the opera-
tive specimens proved pathologically complete remission. Her
follow-up period is continuing (97months) with an uneventful
pregnancy and childbirth before completion of themanuscript.
Our experience with NACT is encouraging because we have
witnessed a stage IB2 case with complete pathological re-
sponse confirmed on VRT + LSC PLDN specimens, a term
delivery 7 years later, and no evidence of disease at 97-month
follow-up. It is of note that another case of NACT in our series
achieved partial pathological remission. Final pathology
proved clear margins and negative nodes. Unfortunately, un-
like the initial histology, this final pathologywas dominated by
neuroendocrine elements. In retrospect, we assume that the
initially predominant squamous elements responded well to
chemotherapy and masked the chemoresistant progression of
the neuroendocrine component. Local and distant recurrence
developed at 3 months postoperatively, and the disease could
not be brought into remission by further chemotherapy. In a
recent review, Plante16 underlined the caution that is needed in
the management of bulky early-stage cases with suboptimal
response to NACT for the notion that partial chemoresistance
seems to be a surrogate indicator of a more aggressive disease.
Within the literature of RT, most reports do not give
details of oncologically insufficient cases, that is, those cases
of RTs that were either aborted or required additional onco-
logic treatment such as radical hysterectomy, chemoradiation,
or chemotherapy. In Wethington and colleagues’14 series of
stage IB1 lesions of more than 2 cm, 9 patients (31%) required
no further oncologic treatment in addition to RT. The other
20 cases required postoperative chemoradiation, hysterectomy,
hysterectomy, and chemoradiation or definitive chemoradiation.
In our series, only 1 patient among the oncologically sufficient
cases had lesion of more than 2 cm, but she underwent NACT
before the procedure. Eventually, RT provided pathologically
complete remission, and following a successful confinement,
she continues to be in complete remission at 97 months of
follow-up. Among our oncologically insufficient cases, there
were 4 patientswith lesionofmore than2 cm.Despite definitive
chemotherapy and conversion to radical hysterectomy followed
by chemoradiotherapy or additional hysterectomy with chemo-
radiotherapy, 3 patients died of their disease at 16, 29, and
58 months of follow-up, respectively. All together we had
5 stage IB1 cases with tumor of more than 2 cm, and 3 of them
had G3 lesion, 4 of them had deep stromal invasion and LVSI,
and 2 of them had positive nodes. The only 1 case of ours with
stage IB1 lesion of more than 2 cm who did not require ad-
ditional oncologic treatment following RT was the one who
received NACT prior to fertility-sparing surgery. Our data do
not support the expansion of indications for RT to stage IB1
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tumors greater than 2 cm, unless effective NACT preceded
surgery. In a recent meta-analysis, Plante16 showed that up-
front RT for bulky early-stage lesions carries a 26% rate of
additional oncologic treatment and 69% rate of fertility
preservation, while RT following NACT carries that of 17.6%
and 80%, respectively.
The 36% rate of additional oncologic treatment in our
series is largely related to risk factors that had been identified
beforeRT such as bulky lesion,G3 tumor, deep stromal invasion,
LVSI, or the presence of aggressive histological component, and
there were only 2 cases in which no preoperative high-risk
feature could be identified (Table 2, patients 3 and 4). The
first of these 2 cases hadmicroscopic residual disease on the RT
specimen and opted for hysterectomy 2 years after RT, which
revealed moderate cervical dysplasia in the stump. In patient 4,
positive isthmic disc indicated conversion to hysterectomy
during the course of RT. There were 2 cases (Table 2, patients
5 and7) inwhich the intraoperative findingofpositive nodes led
to the decision to immediate conversion to radical hysterectomy.
In conclusion, our results suggest that in tumors of more
than 2 cm and in those with deep stromal invasion RT is not
the appropriate intervention. Intermediate risk factors such as
poorly differentiated tumor, nonsquamous/adeno histological
type, and presence of LVSI are also poor prognostic indicators
of the need for oncologic treatment in addition to RT. Reported
meta-analysis of relapse rate and survival after fertility-sparing
surgery proves that many cases of oncologic failures are not
reported in full details. Gynecologic oncologists are encour-
aged to publish more clinicopathologic and follow-up data on
trachelectomy cases in order to improve patient outcome by
the definition of more accurate eligibility criteria.
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